P-IS-35 Distinct molecular signature for borderline ovarian tumors(Oncology 9,Group 96,International Session)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人 日本産科婦人科学会の論文
- 2006-02-01
著者
-
Chang Kai-ming
Institute Of Nanotechnology National Chiao Tung University:section Of Gynecologic Oncology Departmen
-
Hung Yao-ching
Institute Of Nanotechnology National Chiao Tung University:section Of Gynecologic Oncology Departmen
-
Huang G.
National Chiao Tung University Institute Of Nanotechnology
-
Hong Meng-yen
National Chiao Tung University Institute Of Nanotechnology
-
Hung Yao-Ching
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, China Medical University a
-
Chang Kai-Ming
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, China Medical University a
-
Hong Meng-Yen
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, China Medical University a
-
Huang G.
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, China Medical University a
関連論文
- ISO-4 Simultaneous detection of proliferation, apoptosis, invasive ability, and cytoskeletal organization in cancer cells by nanodot arrays device(Group1 Oncology,International Session: Oral Presentation)
- IS-19 Gold nanoparticles as a drug carrierin nanomedicine(Group2 Oncology2,International Session)
- ISO-5 A nanoplatform to assist clinical diagnosis of ovarian cancer(Group1 Oncology,International Session : Oral Presentation)
- IS-47 Application of gold nanoparticle-doxorubicin conjugate as a cancer therapy in nanomedicine(Group6 Oncology6,International Session)
- P-IS-35 Distinct molecular signature for borderline ovarian tumors(Oncology 9,Group 96,International Session)
- P-IS-30 Preventive effect of thea sinensis melanin against cisplatin-induced nephrotoxicity in mice(Oncology 8,Group 95,International Session)